Compugen Ltd. (CGEN)
NASDAQ: CGEN · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Oct 10, 2024, 4:00 PM EDT - Market closed
Compugen Revenue
Compugen had revenue of $6.70M in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to $42.72M, up 469.60% year-over-year. In the year 2023, Compugen had annual revenue of $33.46M with 346.12% growth.
Revenue (ttm)
$42.72M
Revenue Growth
+469.60%
P/S Ratio
3.62
Revenue / Employee
$628,235
Employees
68
Market Cap
154.00M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| biote | 187.23M |
| InfuSystem Holdings | 129.37M |
| The Joint | 120.07M |
| Akoya Biosciences | 93.22M |
| BrainsWay | 36.43M |
| ProQR Therapeutics | 16.90M |
| Generation Bio Co. | 13.17M |
CGEN News
- 3 days ago - Compugen to Present New Clinical Data at SITC 2024 - PRNewsWire
- 4 weeks ago - Compugen to Present at Single Cell Genomics 2024 Conference - PRNewsWire
- 6 weeks ago - Compugen to Present at the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 2 months ago - Compugen Ltd. (CGEN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Compugen Reports Second Quarter 2024 Results - PRNewsWire
- 2 months ago - Compugen Announces FDA Clearance of IND for COM503 for the Treatment of Solid Tumors - PRNewsWire
- 2 months ago - Compugen to Release Second Quarter 2024 Results on Tuesday, August 6, 2024 - PRNewsWire
- 4 months ago - Compugen to Present at Upcoming Antibody Industrial Symposium - PRNewsWire